Completed
Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction
NCT00549939
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
- Sanofi-Aventis Administrative Office Sofia, Bulgaria
- Sanofi-Aventis Administrative Office Laval, Canada
- Sanofi-Aventis Administrative Office Tallinn, Estonia